NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/03/2025
Back to search
Official data from USPTO
BIOEKSEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Quick snapshot
ST13
US500000079360248Class
1, 5, 9, 10, 42, 44
Filing
79360248
Registration
7296255
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/04/2025
Classification
Registered
Trademark type
Combined
Nice classes
1, 5, 9, 10, 42, 44
Filing date
08/19/2022
Registration date
02/06/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/06/2024
Last transaction
01/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
TR
Examiner
GLASSER, CARYN
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word BIOEKSEN with BI and EKSEN in grey and the letter O depicted as a circle in green, with a diagonal ring in grey around the green circle. The color white represents transparent area and is not part of the mark.
Holders and representatives
Holders
B. S. (pessoa física)
Representatives
Michael F. Swartz Egbert, McDaniel & Swartz, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Nucleic acid sequences, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; reagents for scientific purposes for use in nucleic acid isolation and purification; biological preparations for use in industry and science; chemicals for use in biotechnological manufacturing processes; buffer solutions for scientific purposes
Class 5
Pharmaceutical preparations for the central nervous system; chemical preparations for sanitary purposes; in vitro gender prediction test kit; diagnostic kits comprising diagnostic agents, preparations and substances being reagents for medical purposes, namely, for diagnostic testing
Class 9
Laboratory robots; test tubes for laboratory use; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; in vitro diagnostic testing apparatus, other than for medical use, namely, nucleic Acid Extraction robots, real time PCR instruments
Class 10
Medical diagnostic testing apparatus for testing DNA and RNA samples, for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing, cancer cells caused by microbiological agents; medical diagnostic apparatus for testing for viruses; apparatus being diagnostic devices for viral agents for DNA and RNA testing for medical purposes
Class 42
Computer software design; research and development in the field of biotechnology; biochemical engineering services; biotechnology research; research and development of new products for others; consulting services in the field of biotechnology
Class 44
Medical examination services; medical assistance; medical testing for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
35 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/01/2024
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/14/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
05/13/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/06/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/06/2024
GPNX
NOTIFICATION PROCESSED BY IB
11/27/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/21/2023
PUBO
PUBLISHED FOR OPPOSITION
11/21/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/06/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/01/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/17/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2023
RFNT
REFUSAL PROCESSED BY IB
09/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/31/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/31/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/24/2023
GNRT
NON-FINAL ACTION E-MAILED
08/24/2023
CNRT
NON-FINAL ACTION WRITTEN
08/24/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/22/2023
RFNP
REFUSAL PROCESSED BY IB
08/07/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/14/2023
RFRR
REFUSAL PROCESSED BY MPU
07/13/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/08/2023
CNRT
NON-FINAL ACTION WRITTEN
06/07/2023
DOCK
ASSIGNED TO EXAMINER
06/07/2023
MAFR
APPLICATION FILING RECEIPT MAILED
01/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/24/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/13/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/12/2023
Continuous trademark protection
Get notified about every new filing that threatens BIOEKSEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.